Track market-moving stories before they get noisy

Jeffries MD and senior equity research analyst Sheila Kahyaoglu discusses defense stocks amid the Iranian conflict on 'Making Money.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #makingmoney #stocks #defense #military #war #iran #conflict #economy #markets #investing #finance #airlines #travel #fuel #energy #global #politics #political #politicalnews #government

SKYW boosts its fleet with major airline deals and supports shareholders through an expanded repurchase plan.

The collapse of Spirit Airlines is cascading through airports across the US, leaving passengers stranded mid-journey and sending rival carriers into rapid-response mode to contain the damage. Airlines for America President & CEO Chris Sununu joins David Gura and Christina Ruffini on Bloomberg This Weekend to discuss.

Recently, Zacks.com users have been paying close attention to SkyWest (SKYW). This makes it worthwhile to examine what the stock has in store.

SkyWest (SKYW) concluded the recent trading session at $81.9, signifying a -4.38% move from its prior day's close.

IATA nearly halves its 2026 airline profit outlook as oil spikes. Keep LUV, AAL & SKYW on your radar as fuel costs squeeze earnings.

Walker & Dunlop (WD 4.07%) has been a victim of the higher interest rates over the past few years, which have resulted in an extremely slow commercial real estate market. However, this well-run company now offers a 6% dividend yield and just gave some pretty ambitious five-year projections.

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop arranged a joint venture partnership and $132 million redevelopment in Richmond, VA.

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop arranged a $104.5 million loan to finance the Ritz-Carlton Savannah, a 15-story luxury hotel in Savannah, GA.

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop announced that it originated $1.719B in loan proceeds to refinance workforce and affordable housing units for Starwood Capital.

On April 24, 2026, Walker and Dunlop Inc (WD) shares rose 3.5% to a current price of $51.41, showing a notable increase in momentum with a 1-month gain of 16.9%.

Walker & Dunlop, Inc. (WD) Q1 2026 Earnings Call Transcript

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop has arranged $130 million in financing for the redevelopment of a historic former Veterans Affairs (VA) hospital campus.

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop arranged a $101,561,900 loan to refinance Enclave Heritage Flats, a 312-unit multifamily community in Chula Vista, California.

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop arranged more than $223 million in bridge financing for five multifamily communities across the Southeast.

[url="]Walker and Dunlop, Inc.[/url] and [url="]Pretium[/url] announced today that they have closed a $75.7 million bridge loan with Walker and Dunlop Affordable B

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announces Progyny Select, the industry's first fully insured, comprehensive supplemental fertility and family building plan. Available in the U.S., Progyny Select enables small employers to have access to fertility solutions in a fixed premium model.

Progyny, Inc. (NASDAQ: PGNY - Get Free Report) has been given an average recommendation of "Moderate Buy" by the thirteen analysts that are presently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month target

Progyny (PGNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Reports Record First Quarter Revenue of $328.5 MillionEarly Selling Season Activity Reflects Robust Demand for Women's Health and Family Building SolutionsReturned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended March 31, 2026 (“the first quarter of 2026”), as compared to the three-month period ended March 31, 2025 (“the first quarter of 2025” or “the prior year period”). “We're pleased with the strong start to the year, as member engagement trended to the higher end of our expectations, reflecting that people are pursuing the services they need in order to address their family building and overall health and well-being goals,” said Pete Anevski, Chief Executive Officer of Progyny.

Progyny, Inc. (PGNY) Q1 2026 Earnings Call Transcript

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that Progyny's Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026, at 11:20 A.M. Pacific Time / 2:20 P.M. Eastern Time.

Progyny, Inc. (PGNY) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.